Market Insights
The purpose of this strategic research study titled “Cell Culture Media and Reagents Market: Growth, Future Prospects, and Competitive Analysis, 2016–2023” is to offer industry investors, company executives, and industry participants in-depth insights to enable them to make informed strategic decisions related to the opportunities in the cell culture media and reagents market. The primary target audience of this study includes industry investors, cell culture media and reagent manufacturers, distributors, and institutional scholars.
This study classifies the global cell culture media and reagents market into four categories: type of media, type of reagents, applications, and geographical distribution. Based on reagent type, the studied media are albumin (bovine serum albumin, human serum albumin, recombinant human serum albumin), attachment factors, amino acids, growth factors, and cytokines (tumor necrosis factors, insulin-like growth factors, interferons and interleukins, others), hormones, and other reagents.
The types of media studied in this report are classical media, lysogeny broth, protein-free media, specialty media, serum-free media, and chemically defined media. The application areas considered in this study are biopharmaceuticals and therapeutics, drug screening and drug development, regenerative medicine, tissue engineering, stem cell technologies, cancer and biotech research, and others. Market size and volume for each mentioned segment are provided in this report for 2013–2023, along with respective CAGRs (value %) for the period2016–20233.
Geographically, the global cell culture media and reagents market is studied for the following regional markets:
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Market size and volume, and the respective forecasts for these regional and country-level markets, are presented in this study for 2013–2023. Market growth rates for the forecast period 2016–2023 are also included in this report, considering 2015 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global cell culture media and reagents market.
Tools such as the market positioning of key players and an attractive investment proposition provide the readers with insights into the competitive scenario of the global cell culture media and reagents market. This report concludes with a company profiles section that highlights major information about the key players engaged in the development, manufacture, and sale of cell culture media and reagents.
Based on the types of applications, the global cell culture media and reagents market is segmented as follows:
- Classical Media
- Biopharmaceuticals and Therapeutics
- Drug Screening and Drug Development
- Regenerative Medicine and Tissue Engineering
- Stem Cell Technologies
- Cancer and other biotech research
- Others
Cell culture has a bright yet dynamic potential. Cell culture technologists will perpetually work with scientists, biologists, and regulatory authorities to develop and deliver efficacious and safe products. Process intensification, especially in generating gene therapy viral vectors and in antibody and recombinant protein production, remains a critical area to generate sufficient material and lower production costs.
In the case of recombinant protein production, cell culture systems face intense competition from developments in technologies such as the production of transgenic animals. Virus production for gene therapy or vaccines will, however, be inevitably produced in mammalian cells.
Based on the type of media, the global cell culture media market is segmented as follows:
- Classical Media
- Lysogeny Broth
- Protein-free Media
- Specialty Media
- Serum-free Media
- Chemically-defined Media
Media selection is a fundamental procedure in the cell culture process, as it affects every stage of product development and manufacture. The absence of an appropriate cell culture medium results in challenges such as process robustness, scalability, time to market, cost of goods, and others. Improvements in the field of cell culture media are often argued to be the most responsible factor for the increase in the production of titers for therapeutic proteins.
As cell culture media differs from company to company, it is important for media manufacturers to stay ahead of the curve. Thus, media manufacturers have to continually meet the challenge of offering a wide portfolio that meets the needs of the most common cell culture platforms. Cell culture industry experts often opine that end-users look for high-quality media that provide both reproducible results and robust yields.
Chemically defined media does not always provide the desired yield; thus, the inclination towards more complex media increases. The adoption of chemically defined media has been slow but steady for both media manufacturers and bioprocessors. The demand for media has been shifting from serum-based to serum-sparing, serum-free, animal-derived, and chemically defined media.
Based on the type of reagents, the global cell culture reagents market is segmented as follows:
- Albumin (bovine serum albumin, human serum albumin, recombinant serum albumin)
- Attachment Factors
- Amino Acids
- Growth Factors and Cytokines (Tumor Necrosis Factors, Insulin-like Growth Factors (IGF), Interferons and Interleukins, Others)
- Hormones
- Other Reagents
Cell culture reagents are substances that are used to synthesize or detect another substance to be studied in the culture. Some of the most commonly used reagents are cell dissociation reagents, extracellular attachment matrices, cell freezing media, cell washing solutions, growth factors, amino acids, and other related products. The major factor boosting the cell culture reagent market is the rising therapeutic and pharmaceutical research use of cell culture technology.
Moreover, the introduction of advanced products by major market players has further boosted the growth of the cell culture reagents market. Attachment factors held the largest share in the global cell culture reagents market. The advantages of the use of attachment factors in cell culture, such as the prevention of dedifferentiation of cells and the extension of the survival of the culture, are the major drivers of the demand for attachment factors.
For the purpose of this study, the global cell culture media and reagents market is categorized as follows:
- North America (U.S., Canada)
- Europe (U.K., Germany, rest of Europe)
- Asia Pacific (Japan, China, Singapore, South Korea, and the Rest of Asia Pacific)
- Latin America
- Middle East and Africa
In the base year 2015, North America formed the largest market for cell culture media and reagents. The increase in demand for animal component-free media and the rise in demand for automated cell culture systems are the two prime factors contributing to the growth of the cell culture market in North America.
The recent reform in North American cell culture media and reagents regarding the use of human-derived media agents in cell culture will also result in market growth. Outsourcing of bioprocessing activities of pharmaceutical and biotechnology companies in North America to developing markets in Asia Pacific, Brazil, and other developing economies would result in holding back the growth of this market.
It is expected that the cell culture market in Latin America will witness rapid growth in the given period of forecast. The increase in market participants from Latin America, especially countries such as Brazil, Mexico, and Argentina, and the recent trend of outsourcing research processes for various cell culture activities to reduce costs and thereby utilize the expertise of major players in other research and development areas while reducing timelines will motivate the growth of this market.